Lipid mediator class switching during acute inflammation: signals in resolution
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Leukotrienes (LTs) and prostaglandins (PGs) amplify acute inflammation, whereas lipoxins (LXs) have unique anti-inflammatory actions. Temporal analyses of these eicosanoids in clinical and experimental exudates showed early coordinate appearance of LT and PG with polymorphonuclear neutrophil (PMN) recruitment. This was followed by LX biosynthesis, which was concurrent with spontaneous resolution. Human peripheral blood PMNs exposed to PGE2 (as in exudates) switched eicosanoid biosynthesis from predominantly LTB4 and 5-lipoxygenase (5-LO)-initiated pathways to LXA4, a 15-LO product that "stopped" PMN infiltration. These results indicate that first-phase eicosanoids promote a shift to anti-inflammatory lipids: functionally distinct lipid-mediator profiles switch during acute exudate formation to "reprogram" the exudate PMNs to promote resolution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prostaglandin E2 (PGE2) and D2 rapidly initiate the resolution process by inducing the expression of lipid mediators with both anti-inflammatory and pre-resolution functions, e.g., lipoxins [96, 97], resolvins and protectins [98–100], a process known as lipid-mediator class switch [97].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [97]
Citations
Cites
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., & Brady, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1663 · Cited by 638
Inflammation: Basic Principles and Clinical Correlates
Ehrlich, G. E. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.283.1.123 · Cited by 622
Shinmura, K., Tang, X.-L., Wang, Y., Xuan, Y.-T., Liu, S.-Q., Takano, H., Bhatnagar, A., & Bolli, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10197 · Cited by 381
Swan, S. K., Rudy, D. W., Lasseter, K. C., Ryan, C. F., Buechel, K. L., Lambrecht, L. J., Pinto, M. B., Dilzer, S. C., Obrda, O., Sundblad, K. J., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00002 · Cited by 339
Design of Lipoxin A4 Stable Analogs That Block Transmigration and Adhesion of Human Neutrophils
Serhan, C. N., Maddox, J. F., Petasis, N. A., Akritopoulou-Zanze, I., Papayianni, A., Brady, H. R., Colgan, S. P., & Madara, J. L. (1995) · Biochemistry · doi:10.1021/bi00044a041 · Cited by 327
Self-citationActivation of the NF-κB Pathway by Inflammatory Stimuli in Human Neutrophils
McDonald, P. P., Bald, A., & Cassatella, M. A. (1997) · Blood · doi:10.1182/blood.v89.9.3421 · Cited by 324
Prostaglandins, Aspirin-like Drugs and the Oedema of Inflammation
MONCADA, S., FERREIRA, S. H., & VANE, J. R. (1973) · Nature · doi:10.1038/246217a0 · Cited by 312 · cited 1×
“Although PGE 2 induces reactions that mediate several of the cardinal features of inflammation (for example, edem”
BackgroundTessier, P. A., Naccache, P. H., Clark-Lewis, I., Gladue, R. P., Neote, K. S., & McColl, S. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3595 · Cited by 233
Research works printed but not linked: 2
- Light, R. W. Pleural Diseases (Lea & Febiger, Philadelphia, 1990).
- Clish, C. B. et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl Acad Sci USA 96, 8247–8252 (1999). · DOI · Paper page
Cited by
Items 501–600 of 1,000
Brancaleone, V., Dalli, J., Bena, S., Flower, R. J., Cirino, G., & Perretti, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003145 · Cited by 60
“As an example, proinflammatory prostanoids induce LXA4 synthesis in, what has been proposed to be, a “class switching” from the proinflammatory to the proresolving phase of an acute experimental inflammation (49).”
BackgroundDuvall, M. G., Brüggemann, T. R., & Levy, B. D. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.04.003 · Cited by 59
“…lipid mediator class switching occurs as PUFA metabolism switches from pro-inflammatory mediators (e.g., prostaglandins, leukotrienes) to pro-resolving mediators (i.e., chanisms for specialized pro-resolvingmediators in the resolution of rg/10.1016/j.mam.2017.04.003 SPMs) (Levy et al., 2001).”
InfluentialSelf-citationVella, L. D., Markworth, J. F., Farnfield, M. M., Maddipati, K. R., Russell, A. P., & Cameron‐Smith, D. (2019) · Physiological Reports · doi:10.14814/phy2.14108 · Cited by 57
“During this process, interactions between inflammatory and host tissue cells enabled the biosynthesis of resolution mediators (Levy et al. 2001).”
BackgroundInfluentialWelty, F. K., Schulte, F., Alfaddagh, A., Elajami, T. K., Bistrian, B. R., & Hardt, M. (2021) · The FASEB Journal · doi:10.1096/fj.202002471r · Cited by 59
Yang, A., Wu, Y., Yu, G., & Wang, H. (2021) · Respiratory Research · doi:10.1186/s12931-021-01792-y · Cited by 59
Neutrophils in host defense, healing, and hypersensitivity: Dynamic cells within a dynamic host
Siwicki, M. R., & Kubes, P. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.12.004 · Cited by 62
Roles of resolvins in the resolution of acute inflammation
Qu, Q., Xuan, W., & Fan, G.-H. (2014) · Cell Biology International · doi:10.1002/cbin.10345 · Cited by 65
“As an active rather than a passive process (Levy et al., 2001; Serhan, 2007; Stewart, 2009), resolution is characterized by orderly neutralization of noxious materials, non-phlogistic phagocytosis (termed efferocytosis) of apoptotic polymorphonuclear leukocytes (PMNs) by macrophages, and subsequent…”
BackgroundEffects of Lipoxin A4 on antimicrobial actions of neutrophils in sepsis
Wu, B. C., Walker, J., Spur, B. W., Rodríguez, A. R., & Yin, K. (2014) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.11.005 · Cited by 61
Resolution of Inflammation in Asthma
Levy, B. D., Vachier, I., & Serhan, C. N. (2012) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2012.06.006 · Cited by 63
“Resolution is now appreciated to be an active process that terminates acute inflammation.(6,9,10) At present, it is known that efficient restoration of inflamed tissues to their basal state requires that inflammatory cells are effectively cleared and further neutrophil recruitment is abrogated.”
Self-citationIdentification of proresolving and inflammatory lipid mediators in human psoriasis
Sorokin, A. V., Norris, P. C., English, J. T., Dey, A. K., Chaturvedi, A., Baumer, Y., Silverman, J. I. M., Playford, M. P., Serhan, C. N., & Mehta, N. N. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.03.091 · Cited by 58
Self-citationLipoxins and lipoxin analogs in asthma
Levy, B. D. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.010 · Cited by 56
Self-citationTherapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases
Singh, H., & Agrawal, D. K. (2022) · Molecules · doi:10.3390/molecules27217311 · Cited by 64
Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases
Lv, J., Song, X., Luo, Z., Huang, D., Xiao, L., & Zou, K. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1535555 · Cited by 71
Biological Roles of Resolvins and Related Substances in the Resolution of Pain
Lim, J. Y., Park, C., & Hwang, S. W. (2015) · BioMed Research International · doi:10.1155/2015/830930 · Cited by 61
Treating neutrophilic inflammation in COPD by targeting ALX/FPR2 resolution pathways
Bozinovski, S., Anthony, D., Anderson, G. P., Irving, L. B., Levy, B. D., & Vlahos, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.07.007 · Cited by 59
Self-citationInnate immunity is a key factor for the resolution of inflammation in asthma
Barnig, C., & Levy, B. D. (2015) · European Respiratory Review · doi:10.1183/09059180.00012514 · Cited by 59
Self-citationThe Immunophysiology of Male Reproduction
Hedger, M. P. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00019-3 · Cited by 71
“178, 179 Moreover, activated lymphocytes have a limited lifespan, undergoing a process of activation-induced cell death following upregulation of the extrinsic apoptotic signal mediated by interaction of the FAS receptor with its ligand (FASL), eventually leaving behind a relatively small population of long-lived memo…”
BackgroundTreatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword?
Yedgar, S., Krimsky, M., Cohen, Y., & Flower, R. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.07.005 · Cited by 65
Werth, V. P., Hejazi, E. Z., Pena, S. M., Haber, J. S., Zeidi, M., Reddy, N. D., Okawa, J., Feng, R., Bashir, M. M., Gebre, K., et al. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.03.029 · Cited by 57
Neutrophil heterogeneity and plasticity: unveiling the multifaceted roles in health and disease
He, W., Yan, L., Hu, D., Hao, J., Liou, Y., & Luo, G. (2025) · MedComm · doi:10.1002/mco2.70063 · Cited by 69
Tonic inhibition of chemotaxis in human plasma
Malawista, S. E., de Boisfleury Chevance, A., van Damme, J., & Serhan, C. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802572105 · Cited by 54
“) (7), that resolution of inflammation and maintenance of its absence are not passive events.”
BackgroundSelf-citationPalmer, C. D., Mancuso, C. J., Weiss, J. P., Serhan, C. N., Guinan, E. C., & Levy, O. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311145 · Cited by 58
“Little is known regarding the effects of LXs and Rvs on responses of these cells to GNB.”
BackgroundInfluentialSelf-citationKebir, D. E., József, L., & Filep, J. G. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107765 · Cited by 67
“In a murine air-pouch model of inflammation, accumulation of PGE2 induces a switch in lipid mediator synthesis from a predominantly 5-lipoxygenase activity to a 15-lipoxygenase activity generating LXA4, parallel with resolution of inflammation [47].”
Backgroundde Gaetano, M., Butler, E., Gahan, K., Zanetti, A., Marai, M., Chen, J., Cacace, A., Hams, E., Maingot, C., McLoughlin, A., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.10.049 · Cited by 58
Resolving Viral-Induced Secondary Bacterial Infection in COPD: A Concise Review
Wang, H., Anthony, D., Selemidis, S., Vlahos, R., & Bozinovski, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02345 · Cited by 59
Jiménez, M. D. L. R., Lechner, A., Alessandrini, F., Bohnacker, S., Schindela, S., Trompette, A., Haimerl, P., Thomas, D., Henkel, F. D. R., Mourão, A., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay0605 · Cited by 59
Lipoxins: Pro-resolution lipid mediators in intestinal inflammation
Goh, J., Godson, C., Brady, H. R., & MacMathúna, P. (2003) · Gastroenterology · doi:10.1053/gast.2003.50154 · Cited by 60
The acute inflammatory response of teleost fish
Soliman, A. M., & Barreda, D. R. (2023) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2023.104731 · Cited by 58
Lipid metabolites as metabolic messengers in inter-organ communication
Liu, S., Alexander, R., & Lee, C. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.05.002 · Cited by 64
STAMATAKIS, K., & PÉREZ‐SALA, D. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.096 · Cited by 53
“13 A dual nature has also been reported for other mediators like tumor necrosis factor- (TNF- ), interferon- (IFN- ), transforming growth factor- (TGF- ), and some eicosanoids, such as PGE2.(14) Eicosanoids play a key role both in the onset and in the resolution of inflammation.”
BackgroundBiosynthesis of proresolving lipid mediators by vascular cells and tissues
Chatterjee, A., Komshian, S. R., Sansbury, B. E., Wu, B., Mottola, G., Chen, M., Spite, M. R., & Conte, M. S. (2017) · The FASEB Journal · doi:10.1096/fj.201700082r · Cited by 54
“Theproductsof lipoxygenases include both proinflammatory and proresolving lipid mediators, and a “class-switch” toward SPMs is an important step in resolution (44, 45).”
BackgroundBilsborough, J., Fiorino, M. F., & Henkle, B. W. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1851185 · Cited by 57
“Moreover, production of proresolving lipid mediators by neutrophils can contribute to the resolution of pro-inflammatory immune responses [12].”
BackgroundSoundararajan, R., Maurin, M. M., Rodriguez-Silva, J. A., Upadhyay, G., Alden, A. J., Gowda, S. G. B., Schell, M. J., Yang, M., Levine, N. J., Gowda, D., et al. (2024) · Gut · doi:10.1136/gutjnl-2024-332535 · Cited by 63
“44 This normal wound healing process, 10 appeared to be dysregulated in our CRC samples.”
The Role of Lipoxin A4 in Exercise-Induced Bronchoconstriction in Asthma
Tahan, F., Saraymen, R., & Gümüş, H. (2008) · Journal of Asthma · doi:10.1080/02770900701847068 · Cited by 54
“Airway hyper-responsiveness is defined as an abnormal increase in airflow limitation following exposure to a nonallergic stimulus, such as exercise (9, 10).”
BackgroundPillai, P. S., Leeson, S., Porter, T. F., Owens, C. D., Kim, J. M., Conte, M. S., Serhan, C. N., & Gelman, S. (2012) · Inflammation · doi:10.1007/s10753-011-9294-8 · Cited by 52
“It is now clear from results in murine systems in vivo that a temporal class switch occurs in the inflammatory exudate during acute inflammation; leukotrienes and prostaglandins in the initial phase of inflammation, followed by arachidonic acid-derived lipoxins [7, 10] and the novel families of docosahexaenoic acid (D…”
Self-citationIs There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?
Das, U. N. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00182 · Cited by 57
Rostoker, R., Yaseen, H., Schif‐Zuck, S., Lichtenstein, R. G., Rabinovich, G. A., & Ariel, A. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.08.001 · Cited by 58
“During the active resolution of inflammation [1,2] several omponents of the immune response are eliminated [3].”
BackgroundAspirin use and endometrial cancer risk and survival
Takiuchi, T., Blake, E. A., Matsuo, K., Sood, A. K., & Brasky, T. M. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.10.026 · Cited by 51
“Notably, a particular aspirin-triggered lipoxin (ATL), known as LXA4, has been shown to act as an estrogenic substance and has been demonstrated to have in vitro and clinical estrogenic activity on estrogen-responsive endometrial epithelial cell lines [98].”
BackgroundInfluentialMaresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression
Saito‐Sasaki, N., Sawada, Y., Mashima, E., Yamaguchi, T., Ohmori, S., Yoshioka, H., Haruyama, S., Okada, E., & Nakamura, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-23623-9 · Cited by 51
Induction of Bim limits cytokine-mediated prolonged survival of neutrophils
Andina, N. D., Conus, S., Schneider, E. M., Fey, M. F., & Simon, H. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.50 · Cited by 54
Turchini, G. M., Francis, D. S., Du, Z., Olsen, R. E., Ringø, E., & Tocher, D. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819587-1.00003-3 · Cited by 64
Sterile inflammation and the NLRP3 inflammasome in cardiometabolic disease
Cho, S., Fan, Y., & Sweeney, G. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.100624 · Cited by 65
Resolution of inflammation as a novel chemopreventive strategy
Lee, H., Na, H., & Surh, Y. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0363-y · Cited by 55
Polyunsaturated Fatty Acids and Serum C-Reactive Protein: The Rotterdam Study
Muka, T., Jong, J. C. K., Hofman, A., Dehghan, A., Rivadeneira, F., & Franco, O. H. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv021 · Cited by 59
“For instance, they decrease the production of 4-series leukotrienes (11) and promote the formation of lipoxins (11) that have been found to have antiinflammatory properties (12).”
BackgroundWolfer, A. M., Gaudin, M., Taylor-Robinson, S. D., Holmes, E. C., & Nicholson, J. K. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b02794 · Cited by 55
Pro-resolving lipid mediators: Agents of anti-ageing?
Doyle, R., Sadlier, D. M., & Godson, C. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.002 · Cited by 55
Scott, M. A., Woolums, A. R., Swiderski, C. E., Perkins, A., Nanduri, B., Smith, D. R., Karisch, B. B., Epperson, W. B., & Blanton, J. R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227507 · Cited by 63
“During the onset of inflammation, mature leukocytes and macrophages undergo mediator class switching from the production of pro-inflammatory lipid mediators, such as prostaglandins and leukotrienes, to the biosynthesis of SPMs, such as lipoxins and resolvins, to maintain cellular homeostasis and prevent development of…”
BackgroundLipoxins as biomarkers of lupus and other inflammatory conditions
Das, U. N. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-76 · Cited by 52
“During the early phase of inflammation, COX-derived PGs and lipoxygenase-derived LTs initiate exudate formation and inflammatory cell influx [41].”
BackgroundThe Immune Tolerance Role of the HMGB1-RAGE Axis
Watanabe, H., & Son, M. (2021) · Cells · doi:10.3390/cells10030564 · Cited by 54
Bruegel, M., Ludwig, U., Kleinhempel, A., Petros, S., Kortz, L., Ceglarek, U., Holdt, L. M., Thiery, J., & Fiedler, M. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182416f05 · Cited by 50
“Based on these central pathophysiological effects and their superordinate modulatory function on inflammatory reactions, eicosanoids can be considered as biomarkers for sepsis (4, 5).”
BackgroundCash, J. L., Bena, S., Headland, S. E., McArthur, S., Brancaleone, V., & Perretti, M. (2013) · EMBO Reports · doi:10.1038/embor.2013.138 · Cited by 53
“Improved understanding of these endogenous regulatory systems could pave the way for the development of therapeutic approaches to tame inflammatory pathologies [8,9].”
Darwesh, A. M., Sosnowski, D. K., Lee, T. Y., Keshavarz-Bahaghighat, H., & Seubert, J. M. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.04.037 · Cited by 56
Lipoxins and Annexin-1: Resolution of Inflammation and Regulation of Phagocytosis of Apoptotic Cells
Scannell, M., & Maderna, P. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.259 · Cited by 48
“Among these signals, LXs have emerged as mediators of key events in endogenous anti-inflammation and proresolution[3,4,5,6,7,8].”
Cellular resolution of inflammation—catabasis
Widgerow, A. D. (2012) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2011.00754.x · Cited by 48
Mediator Lipidomics: Search Algorithms for Eicosanoids, Resolvins, and Protectins
Serhan, C. N., Lu, Y., Hong, S., & Yang, R. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)32012-0 · Cited by 53
Self-citationLipoxin A4 Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer
Zong, L., Li, J., Chen, X., Chen, K., Li, W., Li, X., Zhang, L., Duan, W., Lei, J., Xu, Q., et al. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6815727 · Cited by 52
“Previously, LXA 4 was regarded as an anti-inflammatory, proresolution lipid that plays important roles in the programmed switch from inflammation to resolution [3, 4].”
BackgroundPro-resolving lipid mediators and therapeutic innovations in resolution of inflammation
Peh, H. Y., & Chen, J. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108753 · Cited by 56
Tocilizumab infusion therapy normalizes inflammation in sporadic ALS patients.
Fiala, M., Mizwicki, M. T., Weitzman, R. E., Magpantay, L. I., & Nishimoto, N. (2013) · Europe PMC (PubMed Central) · Cited by 52
Tyro3, Axl, and Mertk Receptor Signaling in Inflammatory Bowel Disease and Colitis-associated Cancer
Rothlin, C. V., Leighton, J. A., & Ghosh, S. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000050 · Cited by 55
“example, phagocytosis of apoptotic neutrophils leads to the production of PGE2,(61) and PGE2 induces the expression of 15-lipooxygenase and the production of lipoxins.(62) Phagocytosis of apoptotic cells also induces the production of a panoply of tissue repair mediators including cytokines, such as TGFb and IL-10, gr…”
BackgroundBörgeson, E., & Godson, C. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00318 · Cited by 51
“In this way physiological inflammation programs its own resolution and promotes tissue homeostasis (Levy et al., 2001).”
BackgroundLipoxin signaling in neutrophils and their role in periodontal disease
Kantarcı, A., & Dyke, T. E. V. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.019 · Cited by 47
Recchiuti, A., Codagnone, M., Pierdomenico, A. M., Rossi, C., Mari, V. C., Cianci, E., Simiele, F., Gatta, V., & Romano, M. (2014) · The FASEB Journal · doi:10.1096/fj.13-248393 · Cited by 53
“Among them, lipoxins (LXs) represent the prototype of SPM biosynthesized from AA during a lipid mediator (LM) class switching, characteristic of self-contained acute inflammatory reactions (6, 7), as they carry potent immunoresolvent actions when administered therapeutically in experimental diseases (reviewed in ref.”
BackgroundBuchanan, P., McNally, P., Harvey, B. J., & Urbach, V. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00058.2013 · Cited by 52
Das, U. N. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-015-0165-4 · Cited by 49
Wu, B. C., Capilato, J. N., Pham, M., Walker, J. M., Spur, B. W., Rodríguez, A. R., Perez, L. J., & Yin, K. (2016) · The FASEB Journal · doi:10.1096/fj.201500029r · Cited by 50
“It is now believed that effective resolution of infection and/or inflammation is an active process (18, 19, 58).”
BackgroundLipid mediators as regulators of human ILC2 function in allergic diseases
Kónya, V., & Mjösberg, J. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.07.006 · Cited by 52
Dutta, S., Kumar, S., Hyett, J. A., & Salomón, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184370 · Cited by 56
“Additionally, ATL can increase nitric oxide synthesis where the heme oxygenase-1 enzyme is also involved [143] and this effect is responsible for resolving inflammation [143].”
BackgroundHartling, I., Cremonesi, A., Osuna, E., Lou, P., Lucchinetti, E., Zaugg, M., & Hersberger, M. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0644 · Cited by 54
Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
Chávez-Castillo, M., Ortega, Á., Cudris–Torres, L., Durán, P., Rojas, M., Manzano, A., Garrido, B., Salazar, J. J., Silva, A., Rojas-Gómez, D. M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910370 · Cited by 55
Endogenous Receptor Agonists: Resolving Inflammation
Bannenberg, G., Arita, M., & Serhan, C. N. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.188 · Cited by 47
“The generation of LXA4 on its turn was shown to activate the resolution of inflammation[106].”
BackgroundInfluentialSelf-citationTani, Y., Isobe, Y., Imoto, Y., Segi‐Nishida, E., Sugimoto, Y., Arai, H., & Arita, M. (2014) · The FASEB Journal · doi:10.1096/fj.14-251132 · Cited by 48
Orr, S. K., Butler, K. L., Hayden, D., Tompkins, R. G., Serhan, C. N., & Irimia, D. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001312 · Cited by 47
“They stimulate vascular leakage that allows leukocytes to transmigrate into tissues but also act as critical triggers of lipid mediator class switching (19).”
Self-citationCurrent and Emerging Treatments for Postsurgical Cleft Lip Scarring: Effectiveness and Mechanisms
Papathanasiou, E., Trotman, C. A., Scott, A. R., & Dyke, T. E. V. (2017) · Journal of Dental Research · doi:10.1177/0022034517717261 · Cited by 52
“…including efficient removal of leukocytes and return to homeostasis, is an active biological process orchestrated by endogenous signals derived from eicosanoid pathways that signal the physiologic end of the acute inflammatory phase (Levy et al. 2001; Serhan, Chiang, and Van Dyke 2008).”
InfluentialResolvins as Regulators of the Immune System
Seki, H., Sasaki, T., Ueda, T., & Arita, M. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.72 · Cited by 53
“Instillation of TNF-α into the pouches that are created by injection of sterile air induces a PMN-rich inflammatory exudate that is maximal within 2–4 h and reaches PMN resolution by 24 h[13].”
BackgroundPierdomenico, A. M., Recchiuti, A., Simiele, F., Codagnone, M., Mari, V. C., Davì, G., & Romano, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.592352 · Cited by 47
“LXA4 (5, 6, 15S-trihydroxy-7,9,11,13-trans-11-cis-eicosatetraenoic acid) is biosynthesized from arachidonic acid (5) during a lipid mediator class switch, characteristic of inflammation resolution (6), through a multienzymatic pathway involving 5-lipoxygenase and 12- or 15-lipoxygenase (7–9).”
BackgroundTateishi, N., Kakutani, S., Kawashima, H., Shibata, H., & Morita, I. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-30 · Cited by 47
“Furthermore, lipoxin A4 (LXA4), synthesized from ARA by 12/15-lipooxgenase and 5-lipoxygenase, has been identified to have antiinflammatory potential and to play a role in the “resolution phase” that follows and terminates the “inflammation phase” [2,8].”
BackgroundLevy, B. D., Zhang, Q. Y., Bonnans, C., Primo, V., Reilly, J. J., Perkins, D. L., Liang, Y., Arnaout, M. A., Nikolic, B., & Serhan, C. N. (2010) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2010.09.002 · Cited by 50
“PMN were isolated from whole blood (as described [12]) and PMN (10–20 10(6) in HBSS+1.”
Self-citation5-Lipoxygenase–Deficient Mice Infected with Borrelia burgdorferi Develop Persistent Arthritis
Blaho, V. A., Zhang, Y., Hughes-Hanks, J. M., & Brown, C. R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003473 · Cited by 45
“The resolution of inflammation has recently been recognized as an active rather than a passive event, requiring coordinated upregulation of proresolution molecules and downregulation of proinflammatory molecules (59).”
BackgroundAn, J.-U., Hong, S., & Oh, D. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.04.014 · Cited by 45
Clish, C. B., Sun, Y., & Serhan, C. N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5841 · Cited by 46
Self-citationMigration of polymorphonuclear leucocytes is influenced by dendritic cells
Scimone, M. L., Lutzky, V. P., Zittermann, S. I., Maffía, P. C., Jancic, C. C., Buzzola, F. R., Issekutz, A. C., & Chuluyán, E. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02104.x · Cited by 45
Kotlyarov, S. N., & Котлярова, А. А. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147634 · Cited by 56
Gil‐Villa, A. M., Norling, L. V., Serhan, C. N., Cordero, D. R., Rojas, M., & Cadavid, Á. P. (2012) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2012.08.003 · Cited by 46
“In addition, ATL increases nitric oxide synthesis via constitutive and inducible nitric oxide synthases [19].”
Self-citationModulation of innate immunity of patients with Alzheimer's disease by omega‐3 fatty acids
Fiala, M., Kooij, G., Wagner, K., Hammock, B., & Pellegrini, M. (2017) · The FASEB Journal · doi:10.1096/fj.201700065r · Cited by 44
Anti-Inflammatory Effects of OxPAPC Involve Endothelial Cell–Mediated Generation of LXA4
Ke, Y., Zebda, N., Oskolkova, O., Afonyushkin, T., Berdyshev, E. V., Tian, Y., Meng, F., Sarich, N. A., Bochkov, V. N., Wang, J. M., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.310308 · Cited by 48
Parrish, W. R. (2017) · Journal of Exercise Sports & Orthopedics · doi:10.15226/2374-6904/4/2/00156 · Cited by 46
“[79,90,91,96] Transcellular cooperative regulation of the magnitude and duration of the inflammatory response may begin to explain why platelet-leukocyte ratios are emerging as important parameters in the therapeutic efficacy of platelet-rich plasma products.”
BackgroundSpecialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution
Musso, G., Gambino, R., Cassader, M., Paschetta, E., & Sircana, A. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.01.003 · Cited by 47
Archambault, A., Turcotte, C., Martin, C., Provost, V., Larose, M.-C., Laprise, C., Chakir, J., Bissonnette, É. Y., Laviolette, M., Bossé, Y., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202424 · Cited by 43
Neuroinflammation in hypertension: the renin-angiotensin system versus pro-resolution pathways
Mowry, F. E., & Biancardi, V. C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.029 · Cited by 49
Dasilva, G., Muñoz, S., Lois, S., & Medina, I. (2019) · Molecules · doi:10.3390/molecules24122276 · Cited by 46
“Several works indicates that these mediators can resolve acute inflammatory responses with minimal damage to the surrounding tissue in a variety of inflammation situations [12,13].”
BackgroundLateral membrane LXA4 receptors mediate LXA4's anti-inflammatory actions on intestinal epithelium
Kucharzik, T. F., Gewirtz, A. T., Merlin, D., Madara, J., & Williams, I. R. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00507.2001 · Cited by 44
“One of the active counterregulatory pathways involves the action of eicosanoid mediators, including lipoxin A4 (LXA4) and 15-epimeric aspirin-triggered lipoxins (4, 16).”
BackgroundStygar, D., Masironi, B., Eriksson, H., & Sahlin, L. (2007) · Journal of Endocrinology · doi:10.1677/joe-06-0060 · Cited by 49
Clinical Laboratory Tools to Diagnose Inflammation
Das, U. N. (2006) · Advances in clinical chemistry · doi:10.1016/s0065-2423(05)41006-9 · Cited by 45
He, C., Wu, Y., Lai, Y., Cai, Z., Liu, Y., & Lai, L. (2012) · Molecular BioSystems · doi:10.1039/c2mb05503a · Cited by 50
Rong, S., Cao, Q., Liu, M., Seo, J., Jia, L., Boudyguina, E. Y., Gebre, A. K., Colvin, P. L., Smith, T. L., Murphy, R. C., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m022723 · Cited by 43
Awji, E. G., Chand, H. S., Bruse, S., Smith, K. R., Colby, J. K., Mebratu, Y. A., Levy, B. D., & Tesfaigzi, Y. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0142oc · Cited by 47
“COX-2–derived PGE2 can induce 15lipoxygenase (15-LO) expression to promote lipoxin A4 (LXA4) biosynthesis, which mediates the resolution of inflammatory responses (13).”
BackgroundSelf-citationCroasdell, A., Lacy, S. H., Thatcher, T. H., Sime, P. J., & Phipps, R. P. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502331 · Cited by 49
“SPMs are derived from v three and v six fatty acids, precursors that can undergo lipid class switching to produce both pro- and anti-inflammatory molecules in a temporal manner and under different stimuli (40).”
BackgroundOmega-3 fatty acids as an adjunct for periodontal therapy—a review
Chee, B., Park, B., Fitzsimmons, T. R., Coates, A. M., & Bartold, P. M. (2016) · Clinical Oral Investigations · doi:10.1007/s00784-016-1750-2 · Cited by 55
“The change in neutrophil phenotype to generate these protective mediators has been termed a ‘class switch’ [100].”
BackgroundGagliardo, R. P., Gras, D., Grutta, S. L., Chanez, P., Sano, C. D., Albano, G. D., Vachier, I., Montalbano, A. M., Anzalone, G., Bonanno, A., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.11.045 · Cited by 46
“7 12 17 Sex (male/female) 5/2 8/4 11/6 Age (y) 10 (9-10) 9 (8-10) 10 (8-12) NS NS NS Total IgE (KU) 41 (17-52) 503 (308-857) 576 (387-770) <.”
Dorow, J., Becker, S., Kortz, L., Thiery, J., Hauschildt, S., & Ceglarek, U. (2016) · Biopreservation and Biobanking · doi:10.1089/bio.2015.0005 · Cited by 43
Metadata
- Authors
- Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Serhan, Charles N.
- Venue
- Nature Immunology
- Published
- 2001-07
- Volume
- 2
- Issue
- 7
- Pages
- 612-619
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1497700962
- Cited by
- 1,453
- References
- 42
- Citations by year
- 2026: 48 · 2025: 60 · 2024: 61 · 2023: 74 · 2022: 74 · 2021: 81 · 2020: 76 · 2019: 64 · 2018: 69 · 2017: 62 · 2016: 62 · 2015: 63 · 2014: 62 · 2013: 69 · 2012: 60
- FWCI
- 33.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k08hl003788-04)
- National Heart, Lung, and Blood Institute (K08 HL 03788)
- National Institute of General Medical Sciences (GM 38765)
- National Institute of Allergy and Infectious Diseases (F32AI010389, F32-AI10389)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-50305, P01DK050305, K01DK060583)
- National Institute of Dental and Craniofacial Research (P01 DE 13499, P01DE013499)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- lipid mediators, acute inflammation, inflammation resolution, leukotrienes, prostaglandins, lipoxins, eicosanoid biosynthesis, neutrophil recruitment, lipoxin A4, leukotriene B4, 5-lipoxygenase, 15-lipoxygenase, prostaglandin E2, exudate, anti-inflammatory signaling
- MeSH terms
- Animals, Arachidonate 15-Lipoxygenase, Base Sequence, Humans, Hydroxyeicosatetraenoic Acids, Leukotriene B4, Lipids, Male, Mice, Inbred BALB C, Molecular Sequence Data, Neutrophils, Pleural Effusion, RNA, Messenger, Dinoprostone, Molecular Structure, Signal Transduction, DNA, Complementary, Lipoxins, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.